156 related articles for article (PubMed ID: 20153202)
1. Synthesis and characterization of novel 1,2,4-triazine derivatives with antiproliferative activity.
Krauth F; Dahse HM; Rüttinger HH; Frohberg P
Bioorg Med Chem; 2010 Mar; 18(5):1816-21. PubMed ID: 20153202
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure elucidation, determination of the lipophilicity and identification of antitumour activities in vitro of novel 3-(2-furanyl)-8-aryl-7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-ones with a low cytotoxicity towards normal human skin fibroblast cells.
Sztanke K; Tuzimski T; Sztanke M; Rzymowska J; Pasternak K
Bioorg Med Chem; 2011 Sep; 19(17):5103-16. PubMed ID: 21839643
[TBL] [Abstract][Full Text] [Related]
5. Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.
Hu Z; Ma T; Chen Z; Ye Z; Zhang G; Lou Y; Yu Y
J Comb Chem; 2009 Mar; 11(2):267-73. PubMed ID: 19125569
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones.
Sztanke K; Pasternak K; Sztanke M; Kandefer-Szerszeń M; Kozioł AE; Dybała I
Bioorg Med Chem Lett; 2009 Sep; 19(17):5095-100. PubMed ID: 19631534
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
Saczewski F; Maruszak M; Bednarski PJ
Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.
Nie Z; Perretta C; Erickson P; Margosiak S; Lu J; Averill A; Almassy R; Chu S
Bioorg Med Chem Lett; 2008 Jan; 18(2):619-23. PubMed ID: 18055206
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A; Bednarski P; Grunert R
Eur J Med Chem; 2006 Feb; 41(2):219-25. PubMed ID: 16377034
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity of novel 2-amino-4-(4-phenylpiperazino)- 1,3,5-triazine derivatives.
Pomarnacka E; Bednarski P; Grunert R; Reszka P
Acta Pol Pharm; 2004; 61(6):461-6. PubMed ID: 15794339
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiproliferating activity of iron chelators of hydroxyamino-1,3,5-triazine family.
Sun D; Melman G; Letourneau NJ; Hays AM; Melman A
Bioorg Med Chem Lett; 2010 Jan; 20(2):458-60. PubMed ID: 20005708
[TBL] [Abstract][Full Text] [Related]
12. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Xia Q; Zhang L; Zhang J; Sheng R; Yang B; He Q; Hu Y
Eur J Med Chem; 2011 Mar; 46(3):919-26. PubMed ID: 21281992
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic activity of trisubstituted-1,3,5-triazines.
Arya K; Dandia A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3298-304. PubMed ID: 17449247
[TBL] [Abstract][Full Text] [Related]
16. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents.
Bekircan O; Küxük M; Kahveci B; Kolayli S
Arch Pharm (Weinheim); 2005 Aug; 338(8):365-72. PubMed ID: 16041836
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-arylimidazolidin-2-ylidene)hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetate.
Sztanke M; Rzymowska J; Sztanke K
Bioorg Med Chem; 2013 Dec; 21(23):7465-80. PubMed ID: 24126095
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.
Anderson FM; O'Hare CC; Hartley JA; Robins DJ
Anticancer Drug Des; 2000 Apr; 15(2):119-26. PubMed ID: 10901299
[TBL] [Abstract][Full Text] [Related]
19. Cyclocondensation reaction of heterocyclic carbonyl compounds. Part XIII: synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines.
Gucký T; Frysová I; Slouka J; Hajdúch M; Dzubák P
Eur J Med Chem; 2009 Feb; 44(2):891-900. PubMed ID: 18632190
[TBL] [Abstract][Full Text] [Related]
20. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
